IBD Treatment Market Size

Inflammatory Bowel Disease Treatment Market size was valued at USD 23.26 billion in 2024 and is likely to exceed USD 60.79 billion by the end of 2037, registering over 7.6% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of inflammatory bowel disease treatment is evaluated at USD 24.69 billion.. The growth of the market can be attributed to the increasing number of inflammatory bowel diseases, including fecal incontinence, diarrhea, and constipation, across the world. As per the World Health Organization, the second most common cause of death in children under the age of five is diarrhea. Around 525 000 children under five dies from diarrhea each year. Every year, there are around 1.7 billion cases of pediatric diarrheal illness worldwide.

Global IBD treatment market trends such as, higher number of people with inflammatory intestine disease backed by the approval of new biologic drugs for IBD. Hence, the development of novel drugs is anticipated to hike the market growth over the forecast period. It was found that in contrast to the typical review process, which takes 10 months, FDA intends to act on an application within 6 months. Additionally, the rise in demand for IBD treatment in developing nations is also one of the major factors that are predicted to drive the global market for IBD treatments over the forecast period. Drugs that would considerably improve the treatment, diagnosis, or prevention of critical illnesses are given a priority review classification, which focuses attention and resources on their evaluation.